Literature DB >> 17475736

An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results.

Elisabeth Schramm1, Dietrich van Calker, Petra Dykierek, Klaus Lieb, Sabine Kech, Ingo Zobel, Rainer Leonhart, Mathias Berger.   

Abstract

OBJECTIVE: The purpose of this article was to determine the relative efficacy of a psychotherapy program when combined with pharmacotherapy versus medication and clinical management in more severely depressed patients.
METHOD: A randomized controlled trial was conducted in 124 hospitalized patients with DSM-IV major depressive disorder that compared 5 weeks of interpersonal psychotherapy modified for depressed inpatients (15 individual and eight group sessions) plus pharmacotherapy with a regimen that involved medication plus intensive clinical management. The study included a prospective, naturalistic follow-up 3 and 12 months after acute treatment in 97 of 105 treatment completers. The 17-item version of the Hamilton Depression Rating Scale (HAM-D) was the primary outcome measure.
RESULTS: For the intent-to-treat cohort (N=124), analysis of covariance (ANCOVA) showed that patients treated with interpersonal psychotherapy had a significantly greater reduction of depressive symptoms at week 5. Response rates differed significantly between the two treatment conditions, favoring the group that received adjuvant interpersonal psychotherapy (70%) versus clinical management (51%). Remission rates also tended to be higher for patients in the interpersonal psychotherapy group (49% versus 34%). Patients who initially responded to interpersonal psychotherapy exhibited greater treatment gains at the 3-month follow-up evaluation, since only 3% of these subjects relapsed, compared with 25% of the clinical management subjects. Nine months later, this difference lost statistical significance.
CONCLUSIONS: An inpatient treatment program with both brief and intensive psychotherapy plus pharmacotherapy is superior to standard treatment. The results, which add to a growing body of evidence, suggest that this combination treatment may offer an advantage over treatment with medication and clinical management for more severely depressed patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475736     DOI: 10.1176/ajp.2007.164.5.768

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  23 in total

Review 1.  The small specific effects of antidepressants in clinical trials: what do they mean to psychiatrists?

Authors:  Michael E Thase
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

2.  [Guideline-adherent psychiatric-psychotherapeutic hospital care: Normative definition of staff required using the example of depression].

Authors:  M Berger; J Wolff; C Normann; F Godemann; E Schramm; A Klimke; A Heinz; S C Herpertz
Journal:  Nervenarzt       Date:  2015-05       Impact factor: 1.214

3.  [Resource use and financing of guideline-adherent psychotherapeutic inpatient care].

Authors:  C Normann; J Wolff; A Hochlehnert; J P Klein; F Hohagen; K Lieb; J Deckert; P Falkai; M Berger; S C Herpertz
Journal:  Nervenarzt       Date:  2015-05       Impact factor: 1.214

Review 4.  When should psychotherapy be the treatment of choice for major depressive disorder?

Authors:  John C Markowitz
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

5.  [The various facets of psychotherapy].

Authors:  Mathias Berger
Journal:  Neuropsychiatr       Date:  2013-03-05

6.  [Differential indications for psychotherapy exemplified by depression].

Authors:  E Schramm; M Berger
Journal:  Nervenarzt       Date:  2011-11       Impact factor: 1.214

Review 7.  Major depressive disorder: new clinical, neurobiological, and treatment perspectives.

Authors:  David J Kupfer; Ellen Frank; Mary L Phillips
Journal:  Lancet       Date:  2011-12-19       Impact factor: 79.321

8.  Psychoeducational and Cognitive Behavioral Treatment Programs: Implementation and Evaluation From 1995 to 2015 in Kraepelin's Former Hospital.

Authors:  Annette Schaub; Hanns Hippius; Hans-Jürgen Möller; Peter Falkai
Journal:  Schizophr Bull       Date:  2016-07       Impact factor: 9.306

Review 9.  [Affective disorders. The significance of psychotherapeutic approaches].

Authors:  M Berger; E L Brakemeier; C Klesse; E Schramm
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

10.  [Interpersonal psychotherapy and pharmacotherapy for post-stroke depression. Feasibility and effectiveness].

Authors:  W Finkenzeller; I Zobel; S Rietz; E Schramm; M Berger
Journal:  Nervenarzt       Date:  2009-07       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.